Yu, C., Wu, Y., Geng, Y., Yan, H., Zhu, P., Ji, P., . . . Shen, A. Cost-effectiveness of the addition of sintilimab as a first-line therapy for locally advanced or metastatic oesophageal squamous cell carcinoma: A Chinese healthcare system perspective. BMC.
Chicago Style (17th ed.) CitationYu, Cuicui, et al. Cost-effectiveness of the Addition of Sintilimab as a First-line Therapy for Locally Advanced or Metastatic Oesophageal Squamous Cell Carcinoma: A Chinese Healthcare System Perspective. BMC.
MLA (9th ed.) CitationYu, Cuicui, et al. Cost-effectiveness of the Addition of Sintilimab as a First-line Therapy for Locally Advanced or Metastatic Oesophageal Squamous Cell Carcinoma: A Chinese Healthcare System Perspective. BMC.
Warning: These citations may not always be 100% accurate.